Peripheral arterial disease, caused by atherosclerotic narrowing of the arteries supplying the limbs, is widely regarded as a local disease of the legs and, particularly when asymptomatic, as relatively benign. Both impressions are inaccurate.…
Radiotherapy and immunotherapy combination has been a field of intense investigation globally over the past decade. The phase 3 randomised clinical trial (SWOG/NRG S1914) in The Lancet by Megan E Daly and colleagues,1 conducted in the USA, evaluated whether adding perioperative atezolizumab (neoadjuvant, concurrent,…